Graves' Disease Remission Study: MycoMeth Combo — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Graves' Disease Remission Study: MycoMeth Combo — Stella

Home/Graves' Disease/

View on ClinicalTrials.gov

Recruiting

Back to Graves' Disease trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Xiao Fangsen, Xiamen, Fujian

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

The First Affiliated Hospital of Xiamen University

Enrollment target

~205 participants

Started

October 2023

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 60 Years

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.